- Home
- DVAX
as 12-17-2024 4:00pm EST
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 1.7B | IPO Year: | 2004 |
| Target Price: | $22.00 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.15 | EPS Growth: | -67.55 |
| 52 Week Low/High: | $9.74 - $15.01 | Next Earning Date: | 11-07-2024 |
| Revenue: | $260,810,000 | Revenue Growth: | -27.79% |
| Revenue Growth (this year): | 21.64% | Revenue Growth (next year): | 19.81% |
Latest Dynavax Technologies Corporation News
DVAX Breaking Stock News: Dive into DVAX Ticker-Specific Updates for Smart Investing
Argus Research
7 days ago
DVAX: What does Argus have to say about DVAX?
Argus Research
14 days ago
DVAX: What does Argus have to say about DVAX?
Simply Wall St.
15 days ago
Exploring High Growth Tech Stocks In The United States December 2024
Zacks
21 days ago
Does Dynavax Technologies (DVAX) Have the Potential to Rally 93.52% as Wall Street Analysts Expect?
Argus Research
21 days ago
DVAX: What does Argus have to say about DVAX?
PR Newswire
21 days ago
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
Zacks
23 days ago
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?
Insider Monkey
a month ago
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode
Compare DVAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DVAX Dynavax Technologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.